Headlines Covid-19 Specialties Trending Feeds Videos

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19

Mashup Score: 2

JAMA Network - In this issue of JAMA, Gottlieb et al1 report the findings of the ongoing BLAZE-1 (Blocking Viral Attachment and Cell Entry with SARS-CoV-2 Neutralizing
  • The US FDA has issued EUAs for bamlanivimab and for casirivimab+imdevimab for outpatients w mild- moderate symptoms of #COVID19 and risk factors for progression to severe disease (advanced age, obesity, diabetes, CKD, immunosuppression) https://t.co/VX4DVR3ZCX @PreetiNMalani